The American College of Obstetricians and Gynecologists (ACOG) Practice Advisories are issued whenever information on a clinical issue requiring a rapid response is released. Below are recent ACOG Practice Advisories that may be of importance to our TCHMB readers and collaborators. (See also Withdrawn Practice Advisories.)
A critical element of the strategy to eliminate HBV in the United States is the prevention of perinatal transmission.
On December 14, 2017, the Agency for Healthcare Research and Quality (AHRQ) released a comparative effectiveness review on the management of uterine fibroids.
On December 7, 2017, a cohort study analyzing the risk of invasive breast cancer in women who used hormonal contraception was published in the New England Journal of Medicine.
In evaluating all the available scientific information, the results from the September 2017 study do not warrant changing the current recommendation.
If these medications are used, obstetrician-gynecologists should be aware of the benefits and risks associated with these medications.